A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture

NCT05060406 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

448

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: LY06006

Sponsor

Luye Pharma Group Ltd.

Collaborators

[object Object]